GFC Life Science Co., Ltd

388610 · KQ · Healthcare / Biotechnology

4,005.00KRW-225.00 (-5.32%)

Price History

Full chart

Market Stats

Previous Close4,230.00

Open4,230.00

Day Range3,985.00 – 4,320.00

52-Week Range4,460.00 – 21,750.00

Volume18.23K

Market Cap29.26B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta0.71

50-Day Avg5,633.00

200-Day Avg8,775.28

About

GFC Life Science Co., Ltd develops cosmetic, food, and medical materials. The company develops bio-materials in the areas of human bio-technology, bio-phytochemistry, bio-fermentation, unique bio-technology, and biocompatible formula technology. It also offers scientific and systematic research services on human application testing. The company was formerly known as GFC Co., Ltd and changed its name to GFC Life Science Co., Ltd in 2018. GFC Life Science Co., Ltd was founded in 2002 and is headquartered in Hwaseong-si, South Korea.

Company Details

SectorHealthcare
IndustryBiotechnology
Headquarters823, Dongtansunhwan-daero, Hwaseong-si, South Korea, 18471, Korea
Websitehttps://www.gfcos.co.kr

Financials

Income Statement

Currency: KRW	2023-12-31	2024-12-31	2025-12-31
Total Revenue	15.43B	16.80B	17.71B
Growth (%)	-	+8.88%	+5.42%
Cost of Revenue	8.63B	8.93B	9.21B
Gross Profit	6.81B	7.88B	8.51B
Gross Margin	44.11%	46.88%	48.04%
Operating Expense	6.10B	6.17B	8.12B
Operating Income	703.53M	1.70B	386.26M
Operating Margin	4.56%	10.14%	2.18%
EBITDA	5.21B	-2.66B	2.11B
EBITDA Margin	33.73%	-15.80%	11.93%
Net Income	2.10B	-5.95B	555.43M
Net Income Margin	13.63%	-35.39%	3.14%
R&D	1.17B	1.55B	2.04B
R&D as % of Total Revenue	7.59%	9.24%	11.54%
Interest Expense	1.50B	1.49B	298.44M
Interest Expense % of Total Revenue	9.71%	8.89%	1.68%

Balance Sheet

Currency: KRW	2023-12-31	2024-12-31	2025-12-31
Total Assets	18.84B	20.06B	33.83B
Total Liabilities	20.00B	9.16B	10.03B
Total Equity	-1.16B	10.90B	23.80B
Cash	1.48B	1.54B	7.47B
Net Debt	4.85B	4.83B	-

Cash Flow

Currency: KRW	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	2.27B	2.97B	1.37B
Capital Expenditure	675.78M	3.01B	7.71B
Free Cash Flow	1.59B	-43.78M	-6.34B
FCF to OCF	70.22%	-1.48%	-464.14%

Earnings

Report Date	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-
EPS Actual	17.00	-54.97	89.53	90.40	78.80
Surprise	-	-	-	-	-
Timing	-	-	-	-	-

Key Statistics & Ratios

Market Cap29.26B

Enterprise Value32.83B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.52

Price / Book1.20

Revenue (TTM)19.24B

Gross Profit (TTM)9.61B

EBITDA2.70B

Profit Margin5.59%

Operating Margin10.64%

Return on Equity4.47%

Return on Assets1.48%

Shares Outstanding5.29M

Shares Float3.31M

Beta0.71

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jul 24, 20233:1